With your support and other donors, APFED can continue its mission of improving the lives of those living with eosinophilic disorders.
Donate Today
First Tracks Bio is sponsoring a Phase 1b clinical research study of the investigational monoclonal...
Find Out More
APFED is dedicated to keeping our community informed about the latest scientific advancements in eosinophil-associated...
Find Out More
This summer, patients, caregivers, healthcare professionals, researchers, and advocates came together for Eos Connection 2026,...
Find Out More
One of the highlights of APFED’s conference this year was the opportunity to recognize the...
Find Out More
APFED Opposes Proposed Federal Research Funding Rule; Urges Community Action The American Partnership for Eosinophilic...
Find Out More
New Initiative Urges Earlier Recognition of a Frequently Missed Chronic Disease BETHESDA, MD AND ATLANTA,...
Find Out MoreThere is a founding principle within APFED: “We Get It!” And we do. Our founder’s intimate experience with eosinophilic gastroenteritis and frustration out of the lack of resources available led to the building of an organization rallied around change. APFED was born out of necessity.
The American Partnership for Eosinophilic Disorders (APFED) is a 501c3 nonprofit organization founded in December 2001 by a group of mothers of young children living with eosinophil-associated diseases. We are a patient advocacy group dedicated to improving the lives of those living with eosinophilic disorders.
Mission Statement:
To passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.
Eosinophils are a type of white blood celland they play an important part of our immune system. Eosinophils help us fight off certain types of infections, such as parasites. Eosinophil-associated diseases are chronic and require long term management. The symptoms may be debilitating and often lead to missed time at school and work, and may greatly impact a patient’s quality of life.